177 related articles for article (PubMed ID: 27500496)
1. A colitogenic memory CD4+ T cell population mediates gastrointestinal graft-versus-host disease.
Zhou V; Agle K; Chen X; Beres A; Komorowski R; Belle L; Taylor C; Zhu F; Haribhai D; Williams CB; Verbsky J; Blumenschein W; Sadekova S; Bowman E; Ballantyne C; Weaver C; Serody DA; Vincent B; Serody J; Cua DJ; Drobyski WR
J Clin Invest; 2016 Sep; 126(9):3541-55. PubMed ID: 27500496
[TBL] [Abstract][Full Text] [Related]
2. Pathogenic Bhlhe40+ GM-CSF+ CD4+ T cells promote indirect alloantigen presentation in the GI tract during GVHD.
Piper C; Zhou V; Komorowski R; Szabo A; Vincent B; Serody J; Alegre ML; Edelson BT; Taneja R; Drobyski WR
Blood; 2020 Feb; 135(8):568-581. PubMed ID: 31880771
[TBL] [Abstract][Full Text] [Related]
3. IL-7 promotes long-term in vitro survival of unique long-lived memory subset generated from mucosal effector memory CD4+ T cells in chronic colitis mice.
Takahara M; Nemoto Y; Oshima S; Matsuzawa Y; Kanai T; Okamoto R; Tsuchiya K; Nakamura T; Yamamoto K; Watanabe M
Immunol Lett; 2013; 156(1-2):82-93. PubMed ID: 24070768
[TBL] [Abstract][Full Text] [Related]
4. Bone marrow retaining colitogenic CD4+ T cells may be a pathogenic reservoir for chronic colitis.
Nemoto Y; Kanai T; Makita S; Okamoto R; Totsuka T; Takeda K; Watanabe M
Gastroenterology; 2007 Jan; 132(1):176-89. PubMed ID: 17241870
[TBL] [Abstract][Full Text] [Related]
5. Enhancement of Graft-Versus-Host Disease Control Efficacy by Adoptive Transfer of Type 1 Regulatory T Cells in Bone Marrow Transplant Model.
Jeon YW; Lim JY; Im KI; Kim N; Nam YS; Song YJ; Cho SG
Stem Cells Dev; 2019 Jan; 28(2):129-140. PubMed ID: 30381994
[TBL] [Abstract][Full Text] [Related]
6. Granzyme B-Mediated Activation-Induced Death of CD4+ T Cells Inhibits Murine Acute Graft-versus-Host Disease.
Du W; Leigh ND; Bian G; O'Neill RE; Mei L; Qiu J; Chen GL; Hahn T; Liu H; McCarthy PL; Cao X
J Immunol; 2015 Nov; 195(9):4514-23. PubMed ID: 26392464
[TBL] [Abstract][Full Text] [Related]
7. Paradoxical effects of interleukin-18 on the severity of acute graft-versus-host disease mediated by CD4+ and CD8+ T-cell subsets after experimental allogeneic bone marrow transplantation.
Min CK; Maeda Y; Lowler K; Liu C; Clouthier S; Lofthus D; Weisiger E; Ferrara JL; Reddy P
Blood; 2004 Nov; 104(10):3393-9. PubMed ID: 15280194
[TBL] [Abstract][Full Text] [Related]
8. Donor-derived IL-17A and IL-17F deficiency triggers Th1 allo-responses and increases gut leakage during acute GVHD.
Odak I; Depkat-Jakob A; Beck M; Jarek M; Yu Y; Seidler U; David S; Ganser A; Förster R; Prinz I; Koenecke C
PLoS One; 2020; 15(4):e0231222. PubMed ID: 32251446
[TBL] [Abstract][Full Text] [Related]
9. CD4⁺ T cells from IPEX patients convert into functional and stable regulatory T cells by FOXP3 gene transfer.
Passerini L; Rossi Mel E; Sartirana C; Fousteri G; Bondanza A; Naldini L; Roncarolo MG; Bacchetta R
Sci Transl Med; 2013 Dec; 5(215):215ra174. PubMed ID: 24337481
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-12 preserves the graft-versus-leukemia effect of allogeneic CD8 T cells while inhibiting CD4-dependent graft-versus-host disease in mice.
Yang YG; Sergio JJ; Pearson DA; Szot GL; Shimizu A; Sykes M
Blood; 1997 Dec; 90(11):4651-60. PubMed ID: 9373279
[TBL] [Abstract][Full Text] [Related]
11. TNF-TNFR2 interactions are critical for the development of intestinal graft-versus-host disease in MHC class II-disparate (C57BL/6J-->C57BL/6J x bm12)F1 mice.
Brown GR; Lee E; Thiele DL
J Immunol; 2002 Mar; 168(6):3065-71. PubMed ID: 11884480
[TBL] [Abstract][Full Text] [Related]
12. Induced regulatory T cells promote tolerance when stabilized by rapamycin and IL-2 in vivo.
Zhang P; Tey SK; Koyama M; Kuns RD; Olver SD; Lineburg KE; Lor M; Teal BE; Raffelt NC; Raju J; Leveque L; Markey KA; Varelias A; Clouston AD; Lane SW; MacDonald KP; Hill GR
J Immunol; 2013 Nov; 191(10):5291-303. PubMed ID: 24123683
[TBL] [Abstract][Full Text] [Related]
13. The influence of CD4 T-cell subsets on control of CD4 T-cell-mediated graft-versus-host disease.
Moncrieffe H; Coles M; Stockinger B
Immunology; 2008 Dec; 125(4):459-68. PubMed ID: 18498346
[TBL] [Abstract][Full Text] [Related]
14. Combination cell therapy using mesenchymal stem cells and regulatory T-cells provides a synergistic immunomodulatory effect associated with reciprocal regulation of TH1/TH2 and th17/treg cells in a murine acute graft-versus-host disease model.
Lim JY; Park MJ; Im KI; Kim N; Jeon EJ; Kim EJ; Cho ML; Cho SG
Cell Transplant; 2014 Apr; 23(6):703-14. PubMed ID: 23452894
[TBL] [Abstract][Full Text] [Related]
15. The Heteromeric Complex Formed by Dopamine Receptor D
Osorio-Barrios F; Navarro G; Campos J; Ugalde V; Prado C; Raïch I; Contreras F; López E; Espinoza A; Lladser A; Franco R; Pacheco R
Cell Mol Gastroenterol Hepatol; 2021; 12(2):489-506. PubMed ID: 33864900
[TBL] [Abstract][Full Text] [Related]
16. Absence of regulatory T-cell control of TH1 and TH17 cells is responsible for the autoimmune-mediated pathology in chronic graft-versus-host disease.
Chen X; Vodanovic-Jankovic S; Johnson B; Keller M; Komorowski R; Drobyski WR
Blood; 2007 Nov; 110(10):3804-13. PubMed ID: 17693581
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow-mesenchymal stem cells are a major source of interleukin-7 and sustain colitis by forming the niche for colitogenic CD4 memory T cells.
Nemoto Y; Kanai T; Takahara M; Oshima S; Nakamura T; Okamoto R; Tsuchiya K; Watanabe M
Gut; 2013 Aug; 62(8):1142-52. PubMed ID: 23144054
[TBL] [Abstract][Full Text] [Related]
18. Antigen-dependent suppression of alloresponses by Foxp3-induced regulatory T cells in transplantation.
Albert MH; Liu Y; Anasetti C; Yu XZ
Eur J Immunol; 2005 Sep; 35(9):2598-607. PubMed ID: 16078276
[TBL] [Abstract][Full Text] [Related]
19. CC chemokine receptor 9 expression defines a subset of peripheral blood lymphocytes with mucosal T cell phenotype and Th1 or T-regulatory 1 cytokine profile.
Papadakis KA; Landers C; Prehn J; Kouroumalis EA; Moreno ST; Gutierrez-Ramos JC; Hodge MR; Targan SR
J Immunol; 2003 Jul; 171(1):159-65. PubMed ID: 12816994
[TBL] [Abstract][Full Text] [Related]
20. Alloreactive memory T cells are responsible for the persistence of graft-versus-host disease.
Zhang Y; Joe G; Hexner E; Zhu J; Emerson SG
J Immunol; 2005 Mar; 174(5):3051-8. PubMed ID: 15728519
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
